30
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          Despite the efficacy of pre-exposure prophylaxis (PrEP) in preventing HIV transmission, few studies have evaluated PrEP use and retention in care outcomes in real-world settings outside of clinical trials.

          Methods

          Data were collected from PrEP clinical care programmes in three mid-size US cities: Providence, Rhode Island (RI); Jackson, Mississippi (MS); and St. Louis, Missouri (MO). We assessed the demographic and social characteristics of patients prescribed PrEP and documented their insurance and copayment experiences. We assessed retention in PrEP care at three and six months. Multivariate analyses were used to predict retention in care among men who have sex with men (MSM). HIV acquisition among the cohort was also assessed.

          Results

          A total of 267 (RI: 117; MS: 88; MO: 62) patients were prescribed PrEP; 81% filled prescriptions (RI: 73%; MS: 82%; MO: 94%; p<0.001). Patients in MS and MO were more commonly African American than in RI (72% and 26% vs. 7%, respectively), but less frequently Latino (2% and 3% vs. 24%, respectively). More patients reported living below the federal poverty line in MS (52%) compared to MO (23%) and RI (26%). Most patients were MSM (RI: 92%; MS: 88%; MO: 84%). The majority of MSM reported recent condomless anal sex (RI: 70%; MS: 65%; MO: 75%). Among 171 patients prescribed PrEP at least six months beforehand, 72% were retained in care at three months (RI: 68%; MS: 70%; MO: 87%; p=0.12) and 57% were retained in PrEP care at six months (RI: 53%: MS: 61%; MO: 63%; p=0.51). Insurance status and medication costs were not found to be significant barriers for obtaining PrEP. Three patients became infected with HIV during the six-month period after being prescribed PrEP (1.1%; 3/267), including one in RI (suspected acute HIV infection), one in MO (confirmed poor adherence) and one in MS (seroconverted just prior to initiation).

          Conclusions

          PrEP initiation and retention in care differed across these distinct settings. In contrast, retention in PrEP care was consistently suboptimal across sites. Further research is needed to identify the individual, social and structural factors that may impede or enhance retention in PrEP care

          Related collections

          Most cited references36

          • Record: found
          • Abstract: found
          • Article: not found

          Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

          Antiretroviral chemoprophylaxis before exposure is a promising approach for the prevention of human immunodeficiency virus (HIV) acquisition. We randomly assigned 2499 HIV-seronegative men or transgender women who have sex with men to receive a combination of two oral antiretroviral drugs, emtricitabine and tenofovir disoproxil fumarate (FTC-TDF), or placebo once daily. All subjects received HIV testing, risk-reduction counseling, condoms, and management of sexually transmitted infections. The study subjects were followed for 3324 person-years (median, 1.2 years; maximum, 2.8 years). Of these subjects, 10 were found to have been infected with HIV at enrollment, and 100 became infected during follow-up (36 in the FTC-TDF group and 64 in the placebo group), indicating a 44% reduction in the incidence of HIV (95% confidence interval, 15 to 63; P=0.005). In the FTC-TDF group, the study drug was detected in 22 of 43 of seronegative subjects (51%) and in 3 of 34 HIV-infected subjects (9%) (P<0.001). Nausea was reported more frequently during the first 4 weeks in the FTC-TDF group than in the placebo group (P<0.001). The two groups had similar rates of serious adverse events (P=0.57). Oral FTC-TDF provided protection against the acquisition of HIV infection among the subjects. Detectable blood levels strongly correlated with the prophylactic effect. (Funded by the National Institutes of Health and the Bill and Melinda Gates Foundation; ClinicalTrials.gov number, NCT00458393.).
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women

            New England Journal of Medicine, 367(5), 399-410
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.

              Antiretroviral preexposure prophylaxis has been shown to reduce the risk of human immunodeficiency virus type 1 (HIV-1) infection in some studies, but conflicting results have been reported among studies, probably due to challenges of adherence to a daily regimen.
                Bookmark

                Author and article information

                Journal
                J Int AIDS Soc
                J Int AIDS Soc
                JIAS
                Journal of the International AIDS Society
                International AIDS Society
                1758-2652
                13 June 2016
                2016
                : 19
                : 1
                : 20903
                Affiliations
                [1 ]Division of Infectious Diseases, The Miriam Hospital, Brown University, Providence, RI, USA
                [2 ]Division of Infectious Diseases, University of Mississippi Medical Center, Jackson, MS, USA
                [3 ]Division of Infectious Diseases, Washington University in St. Louis, St. Louis, MO, USA
                [4 ]Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA
                [5 ]Department of Sociomedical Sciences, Columbia University, New York, NY, USA
                [6 ]Department of Social Work, North Carolina Agricultural and Technical State University, Greensboro, NC, USA
                [7 ]The Fenway Institute, Fenway Health, Boston, MA, USA
                [8 ]Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA
                [9 ]Department of Global Health and Population, Harvard School of Public Health, Boston, MA, USA
                [10 ]Department of Epidemiology, Brown University School of Public Health, Providence, RI, USA
                [11 ]Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI, USA
                Author notes
                [§ ] Corresponding author: Philip A Chan, Division of Infectious Diseases, The Miriam Hospital, 1125 North Main Street, Providence, RI 02906, USA. Tel: +1 (401) 793 4859. Fax: +(401) 793 4709. ( pchan@ 123456lifespan.org )
                Article
                20903
                10.7448/IAS.19.1.20903
                4908080
                27302837
                85f481fd-de6c-4167-a346-d20c25852da3
                © 2016 Chan PA et al; licensee International AIDS Society

                This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 05 January 2016
                : 26 April 2016
                : 12 May 2016
                Categories
                Short Report

                Infectious disease & Microbiology
                pre-exposure prophylaxis,implementation,men who have sex with men,hiv

                Comments

                Comment on this article